New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析

◆英語タイトル:New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:DATA904C15308
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

New Zealand Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, food, and aquaculture industries. The company’s products include dietary supplements, carbohydrates, microbiological and cell culture media, pharmaceutical intermediates and ingredients, feed ingredients, excipients and blackcurrant extract. NZP uses various technologies such as enzyme and chemical hydrolyses; large scale aqueous and organic solvent extractions; ion-exchange purification, distillation, ultrafiltration, filtration and centrifugation; crystallisation, milling and chemical synthesis; and spray drying to manufacture its products. NZP is headquartered in Palmerston North, New Zealand.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
New Zealand Pharmaceuticals Ltd – Key Facts
New Zealand Pharmaceuticals Ltd – Key Employees
New Zealand Pharmaceuticals Ltd – Key Employee Biographies
New Zealand Pharmaceuticals Ltd – Key Operational Employees
New Zealand Pharmaceuticals Ltd – Major Products and Services
New Zealand Pharmaceuticals Ltd – History
New Zealand Pharmaceuticals Ltd – Company Statement
New Zealand Pharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
New Zealand Pharmaceuticals Ltd – Business Description
New Zealand Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
New Zealand Pharmaceuticals Ltd – Strengths
New Zealand Pharmaceuticals Ltd – Weaknesses
New Zealand Pharmaceuticals Ltd – Opportunities
New Zealand Pharmaceuticals Ltd – Threats
New Zealand Pharmaceuticals Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
New Zealand Pharmaceuticals Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
New Zealand Pharmaceuticals Ltd, Key Facts
New Zealand Pharmaceuticals Ltd, Key Employees
New Zealand Pharmaceuticals Ltd, Key Employee Biographies
New Zealand Pharmaceuticals Ltd, Key Operational Employees
New Zealand Pharmaceuticals Ltd, Major Products and Services
New Zealand Pharmaceuticals Ltd, History
New Zealand Pharmaceuticals Ltd, Subsidiaries
New Zealand Pharmaceuticals Ltd, Joint Venture
New Zealand Pharmaceuticals Ltd, Key Competitors
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
New Zealand Pharmaceuticals Ltd, Recent Deals Summary

List of Figures
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hummingbird Diagnostics GmbH:企業の製品パイプライン分析
    Summary Hummingbird Diagnostics GmbH (Hummingbird), is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates and analyzes genomic biomarkers especially …
  • Rekah Pharmaceutical Industry Ltd (REKA):企業の財務・戦略的SWOT分析
    Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cambridge Research Biochemicals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cambridge Research Biochemicals Ltd (CRB) is a provider of custom peptide and custom antibody producer for research activities. The company offers products such as stock peptides, peptide nucleic acid, florescent dyes, and immunological products and labeling kits. Its immunological products …
  • The Landis Taipei Hotel Co., Ltd:企業の戦略・SWOT・財務情報
    The Landis Taipei Hotel Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary The Landis Taipei Hotel Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Shadin Avionics LP:企業の戦略・SWOT・財務分析
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Cayenne Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc is a medical device company that designs, develops, and markets soft tissue reconstruction products. The company offers soft tissue reconstruction solutions for knee, shoulder and extremities. Its knee replacem …
  • Alimera Sciences Inc (ALIM):企業の財務・戦略的SWOT分析
    Alimera Sciences Inc (ALIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Wave 80 Biosciences Inc:企業の製品パイプライン分析2018
    Summary Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables. The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other …
  • GI Dynamics Inc (GID)-製薬・医療分野:企業M&A・提携分析
    Summary GI Dynamics Inc (GI Dynamics) is a medical device company that develops and commercializes endoscopy instruments. The company’s product includes EndoBarrier, an endoscopically delivered device therapy that is designed to mimic the mechanisms of metabolic surgery- without altering the anatomy …
  • Immupharma Plc (IMM):企業の財務・戦略的SWOT分析
    Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Valener Inc (VNR)-エネルギー分野:企業M&A・提携分析
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investment companies, the company offers storage, distribution, transportation and allied energy services. The company has interests in Gaz Metro and is its limited partner. Valener, through …
  • H&R GmbH & Co KGaA (2HR):企業の財務・戦略的SWOT分析
    H&R GmbH & Co KGaA (2HR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Xencor Inc (XNCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the …
  • Take-Two Interactive Software, Inc.:企業の戦略・SWOT・財務情報
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Shionogi Inc:企業の戦略的SWOT分析
    Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • J.L.Clark, Inc.:企業の戦略的SWOT分析
    J.L.Clark, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務情報
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PT Es Teler 77:企業の戦略・SWOT・財務情報
    PT Es Teler 77 - Strategy, SWOT and Corporate Finance Report Summary PT Es Teler 77 - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆